For­mer FDA chief von Es­chen­bach steps up his ad­vi­so­ry role at Ma­lin

Dublin-based Ma­lin is tap­ping more of An­drew von Es­chen­bach’s time.

The for­mer FDA chief has signed on as chief med­ical ad­vis­er to the biotech in­vestor, af­ter a stint in the some­what less for­mal po­si­tion of ad­vi­so­ry part­ner.

Ma­lin, which re­cent­ly saw Kel­ly Mar­tin step down as chief in fa­vor of Adri­an Howd, is look­ing for more in­put from von Es­chen­bach for the on­col­o­gy com­pa­nies in its port­fo­lio — like Po­sei­da and Im­muno­core, which is now in the midst of a ma­jor new raise.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER